Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? | Opinion: Yes.
作者信息
Monteiro Leonardo L, Kassouf Wassim
机构信息
Division of Urology, McGill University Health Center, Montreal, Quebec, Canada.
出版信息
Int Braz J Urol. 2017 Mar-Apr;43(2):184-187. doi: 10.1590/S1677-5538.IBJU.2017.02.03.
Abstract
摘要
相似文献
1
Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? | Opinion: Yes.根治性膀胱切除术是大多数肌层浸润性膀胱癌患者的最佳选择？| 观点：是。
Int Braz J Urol. 2017 Mar-Apr;43(2):184-187. doi: 10.1590/S1677-5538.IBJU.2017.02.03.
2
Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? | Opinion: No.根治性膀胱切除术是大多数肌层浸润性膀胱癌患者的最佳选择吗？| 观点：不是。
Int Braz J Urol. 2017 Mar-Apr;43(2):188-191. doi: 10.1590/S1677-5538.IBJU.2017.02.04.
3
Muscle Invasive Bladder Cancer (MIBC) - The Gold Standard Radical Cystectomy or Bladder Preserving Approach, YES or NO?
J Pak Med Assoc. 2018 Oct;68(10):1425-1426.
4
[Alternatives to cystectomy].[膀胱切除术的替代方案]
Urologe A. 2015 Apr;54(4):504-9. doi: 10.1007/s00120-015-3775-6.
5
Non-muscle-invasive bladder cancer: the role of radical cystectomy.非肌层浸润性膀胱癌：根治性膀胱切除术的作用
Urology. 2005 Nov;66(5):917-22. doi: 10.1016/j.urology.2005.05.003.
6
Radical cystectomy--often too late? Yes, but ..根治性膀胱切除术——往往为时已晚？没错，但……
Eur Urol. 2006 Dec;50(6):1129-38. doi: 10.1016/j.eururo.2006.07.056. Epub 2006 Aug 15.
7
Rethinking Radical Cystectomy as the Best Choice for Most Patients With Muscle-Invasive Bladder Cancer.重新审视根治性膀胱切除术作为大多数肌层浸润性膀胱癌患者的最佳选择。
JAMA Oncol. 2016 Jul 1;2(7):856-8. doi: 10.1001/jamaoncol.2016.0152.
8
Invasive T1 bladder cancer: indications and rationale for radical cystectomy.浸润性T1期膀胱癌：根治性膀胱切除术的适应症及理论依据
BJU Int. 2008 Aug;102(3):270-5. doi: 10.1111/j.1464-410X.2008.07743.x. Epub 2008 May 20.
9
The learning curve of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.机器人辅助根治性膀胱切除术的学习曲线：来自国际机器人膀胱切除术协会的结果。
Eur Urol. 2010 Aug;58(2):197-202. doi: 10.1016/j.eururo.2010.04.024. Epub 2010 Apr 23.
10
Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis.低剂量放化疗后行部分或根治性膀胱切除术治疗肌层浸润性膀胱癌：意向性生存分析
Urology. 2008 Aug;72(2):384-8. doi: 10.1016/j.urology.2008.03.017. Epub 2008 May 2.
引用本文的文献
1
(-)-Epigallocatechin-3-Gallate Prevents IL-1β-Induced uPAR Expression and Invasiveness via the Suppression of NF-κB and AP-1 in Human Bladder Cancer Cells.(-)-表没食子儿茶素没食子酸酯通过抑制 NF-κB 和 AP-1 抑制人膀胱癌细胞中 IL-1β 诱导的 uPAR 表达和侵袭。
Int J Mol Sci. 2022 Nov 13;23(22):14008. doi: 10.3390/ijms232214008.
2
Editorial Comment: Factors associated with utilization of neoadjuvant chemotherapy in charlson comorbidity zero non-metastatic muscle-invasive bladder cancer patients.编辑评论：Charlson合并症评分为零的非转移性肌肉浸润性膀胱癌患者新辅助化疗使用的相关因素
Int Braz J Urol. 2021 Jul-Aug;47(4):819-820. doi: 10.1590/S1677-5538.IBJU.2020.0594.1.
3
Review of Experimental Studies to Improve Radiotherapy Response in Bladder Cancer: Comments and Perspectives.改善膀胱癌放疗反应的实验研究综述：评论与展望
Cancers (Basel). 2020 Dec 30;13(1):87. doi: 10.3390/cancers13010087.
本文引用的文献
1
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.保留膀胱的三联疗法治疗肌层浸润性膀胱癌患者的长期疗效：马萨诸塞州综合医院经验的更新分析。
Eur Urol. 2017 Jun;71(6):952-960. doi: 10.1016/j.eururo.2016.12.020. Epub 2017 Jan 9.
2
The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review.淋巴结清扫范围对膀胱癌根治性切除术患者肿瘤学结局的影响：系统评价。
Eur Urol. 2014 Dec;66(6):1065-77. doi: 10.1016/j.eururo.2014.05.031. Epub 2014 Jul 26.
3
Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.根治性膀胱切除术联合多模式治疗在肌层浸润性膀胱癌中的保膀胱作用的批判性分析：一项系统性综述。
Eur Urol. 2014 Jul;66(1):120-37. doi: 10.1016/j.eururo.2014.02.038. Epub 2014 Feb 26.
4
Hypofractionated intensity modulated radiation therapy in combined modality treatment for bladder preservation in elderly patients with invasive bladder cancer.适形调强放疗在联合模式治疗老年浸润性膀胱癌保膀胱中的应用。
Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):326-31. doi: 10.1016/j.ijrobp.2013.11.005.
5
Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: results of the BC2001 trial (CRUK/01/004).随机非劣效性试验：对于肌层浸润性膀胱癌，低剂量大体积放疗与标准剂量体积放疗的比较：BC2001 试验（CRUK/01/004）结果。
Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):261-9. doi: 10.1016/j.ijrobp.2013.06.2044.
6
Refining patient selection for neoadjuvant chemotherapy before radical cystectomy.优化根治性膀胱切除术前新辅助化疗的患者选择。
J Urol. 2014 Jan;191(1):40-7. doi: 10.1016/j.juro.2013.07.061. Epub 2013 Jul 30.
7
Lymphadenectomy for bladder cancer at the time of radical cystectomy.根治性膀胱切除术时的膀胱癌淋巴结切除术。
Eur Urol. 2013 Aug;64(2):266-76. doi: 10.1016/j.eururo.2013.04.036. Epub 2013 Apr 29.
8
Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base.美国肌肉浸润性膀胱癌潜在治愈疗法的使用：来自国家癌症数据库的结果。
Eur Urol. 2013 May;63(5):823-9. doi: 10.1016/j.eururo.2012.11.015. Epub 2012 Nov 19.
9
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder.2012 年国际膀胱癌咨询委员会-欧洲泌尿外科学会：浸润性膀胱癌的根治性膀胱切除术和膀胱保存治疗。
Eur Urol. 2013 Jan;63(1):45-57. doi: 10.1016/j.eururo.2012.08.009. Epub 2012 Aug 14.
10
Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer.肌层浸润性膀胱癌放化疗或不放化疗。
N Engl J Med. 2012 Apr 19;366(16):1477-88. doi: 10.1056/NEJMoa1106106.
Zotero 插件